| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00567125 |
| P953 | full work available at URL | http://link.springer.com/article/10.1007/BF00567125/fulltext.html |
| http://link.springer.com/content/pdf/10.1007/BF00567125 | ||
| http://link.springer.com/content/pdf/10.1007/BF00567125.pdf | ||
| P698 | PubMed publication ID | 1233222 |
| P2093 | author name string | U. C. Dubach | |
| J. Raaflaub | |||
| P2860 | cites work | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| Influence of route of administration on drug availability | Q34226637 | ||
| Influence of First-Pass Effect on Availability of Drugs on Oral Administration | Q34704483 | ||
| The estimation of acetanilide and its metabolic products, aniline, N-acetyl p-aminophenol and p-amino-phenol, free and total conjugated, in biological fluids and tissues. | Q34854846 | ||
| The comparative metabolism of phenacetin and N-acetyl-p-aminophenol in man, with particular reference to effects on the kidney | Q44417952 | ||
| Decreased Concentration of Phenacetin in Plasma of Cigarette Smokers | Q44930867 | ||
| Pathogenesis of chronic interstitial nephritis following prolonged analgesic abuse | Q46732585 | ||
| Oral absorption and disposition kinetics of lidocaine hydrochloride in dogs | Q52741754 | ||
| Pharmacokinetic Basis for the Influence of Route of Administration on the Area Under the Plasma Concentration-Time Curve | Q71241398 | ||
| New aspects on the question of phenacetin nephrotoxicity | Q71289979 | ||
| Dose-dependent change in the pattern of phenacetin metabolism in man and its possible significance in analgesic nephropathy | Q71329429 | ||
| Influence of the route of administration on the area under the plasma concentration-time curve | Q72340804 | ||
| The fate of acetophenetidin in man and methods for the estimation of acetophenetidin and its metabolites in biological material | Q80366817 | ||
| P433 | issue | 3-4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| pharmacokinetics | Q323936 | ||
| P304 | page(s) | 261-265 | |
| P577 | publication date | 1975-04-01 | |
| 1975-04-04 | |||
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | On the pharmacokinetics of phenacetin in man | |
| P478 | volume | 8 |
| Q70489168 | A kinetic evaluation of 14CO2 in expired air after 14C-methacetin administration in rats, used for the in vivo study of the metabolism of drugs |
| Q37317619 | Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach |
| Q69940658 | Comparison of the phenacetin and aminopyrine breath tests: effect of liver disease, inducers and cobaltous chloride |
| Q35553197 | Dietary Effects on Drug Metabolism and Transport |
| Q67041786 | Dose dependence of the 14C-aminopyrine breath test. Intrasubject comparison of tracer and pharmacological doses |
| Q51834731 | Dose dependent pharmacokinetics of midazolam. |
| Q39297517 | Effects of phenacetin, paracetamol and caffeine on the erosive activity of acetylsalicylic acid in the rat stomach: dose-response relationships, time course of erosion development and effects on acid secretion |
| Q34257205 | First-pass elimination. Basic concepts and clinical consequences |
| Q58045908 | Identification of phenacetin metabolites in human urine after administration of phenacetin-C2H3: Measurement of futile metabolic deacetylation via HPLC/MS-SPE-NMR and HPLC-ToF MS |
| Q44846316 | Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype. |
| Q34475234 | Oral prednisone for chronic active liver disease: dose responses and bioavailability studies |
| Q69145215 | Pharmacokinetics from a dynamical systems point of view |
| Q42596162 | Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent |
| Q36857756 | Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data |
| Q34513027 | The contribution of genetically determined oxidation status to inter-individual variation in phenacetin disposition |
| Q36554412 | Xenobiotics shape the physiology and gene expression of the active human gut microbiome |